TheraRadar
← Back
Data updated: Mar 29, 2026

SOMERSET

CardiovascularOphthalmologyNeurology
Generics

SOMERSET is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Neurology.

2006
Since
19
Drugs
-
Trials
137
Approved (2yr)

Key Drugs

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
brimonidine tartrate
Ophthalmology
alpha-2 adrenergic receptor 2 indications · 2022
CALCIUM CHLORIDE 10%
calcium chloride
· 2017

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
ATROPINE SULFATE 2026-02-04
Labeling
LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
CUPRIC CHLORIDE 2026-01-26
OLOPATADINE HYDROCHLORIDE 2026-01-06
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 56%
5 drugs
Ophthalmology 33%
3 drugs
Neurology 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Ophthalmology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
Baxter specialty
Cardiovascular, Ophthalmology
AbbVie big-pharma
Neurology, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology